跳至主要内容
临床试验/NCT03174119
NCT03174119Unknown不适用

Luminothérapie Chez Les Patients présentant un état de la Conscience altérée: évaluations Comportementale, de Neuroimagerie et (Neuro)Physiologique.

University of Liege0 个研究点目标入组 50 人开始时间: 2019年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
主要终点
Changes in the Coma Recovery Scale-Revised scores.

研究概览

简要总结

In this randomized, double-blind, placebo controlled project, the investigators would like to assess the effect of a specific light, as compared to placebo light, on wakefulness (circadian rhythms, homeostasy, sleep-wake cycle), awareness (perceptual and self consciousness), cognition (attention, memory) and underlying brain activity (electrophysiology and neuroimaging)

详细描述

The investigators will use behavioral (CRS-R, CAP, actimeter, brainstem reflexes), physiological (body core temperature, saliva, urine, heart rate, blood sample), neuroimaging and neurophysiological tools (PET, fMRI, TMS-EEG, resting-state and auditory paradigm EEG) before, during and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •disorder of consciousness
  • •6 weeks post-injury

排除标准

  • •dysautonomia
  • •acute illnesses (infections with fever)
  • •medication that is known to affect circadian rhythmicity (melatonin)
  • •uncorrected sensorial deficits or documented history of significant neurological, neurosurgical, developpemental or psychiatric disorders
  • •previously known cerebral lesions prior to the brain's insult that lead to disorder of consciousness
  • •any contraindication to MRI, EEG, TMS-EEG, or PET (e.g., electronic implanted devices, active epilepsy, external ventricular drain)
  • •not medically stable

研究组 & 干预措施

Real light exposition by the mean of Luminette®

Active Comparator

All patients will be exposed to a real light (1500 lux, 470 nm) during the treatment phase, 3 times per day (morning, afternoon and evening) for 60 minutes each via goggles providing light at the eyes level. Meanwhile, different assessments will be performed in order evaluating the potential effects of provided light in comparison to placebo ligh. Patients will be given behavioral assessments (Coma Recovery Scale-Revised, Nociception Coma Scale-Revised, brainstem reflexes,...), physiological (body core temperature, saliva, urine, heart rate, blood sample), neuroimaging and neurophysiological tools (PET, fMRI, TMS-EEG, resting-state and auditory paradigm EEG) before, during and after treatment.

干预措施: Light therapy - active (Device)

Placebo light exposition by the mean of Luminette®

Placebo Comparator

All patients will also be exposed to a placebo light (80 lux, 470 nm) during the treatment phase, 3 times per day (morning, afternoon and evening) for 60 minutes each via goggles providing light at the eyes level. Meanwhile, different assessments will be performed in order evaluating the potential effects of provided light in comparison to placebo light. Patients will be given behavioral assessments (Coma Recovery Scale-Revised, Nociception Coma Scale-Revised, brainstem reflexes,...), physiological (body core temperature, saliva, urine, heart rate, blood sample), neuroimaging and neurophysiological tools (PET, fMRI, TMS-EEG, resting-state and auditory paradigm EEG) before, during and after treatment.

干预措施: Placebo light (Device)

结局指标

主要结局

Changes in the Coma Recovery Scale-Revised scores.

时间窗: 4 weeks study

Identify the improvement in sleep-wake cycle and circadian rhythm after the real light therapy exposure, with behavioral analyses and diagnosis through the CRS-R results.

次要结局

  • Change in sleep-wake cycles through the actimetry, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in sleep-wake cycles through the hemodynamic function of the brain with functional Magnetic Resonance Imaging, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in sleep-wake cycles through the electrical activity of the brain with electroencephalography, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in sleep-wake cycles through analyses of melatonine hormone, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in sleep-wake cycles through temperature measurements, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in sleep-wake cycles through the brain metabolism with Positron Emission Tomography, after the exposition of real light instead of placebo light.(4 weeks study)
  • Change in the outcomes by the assessment of the Glasgow Outcome Scale Extended, after the study.(2 years after)
  • Change in sleep-wake cycles through the Nociception Coma Scale-Revised, after the exposition of real light instead of placebo light.(4 weeks study)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olivia Gosseries

Dr

University of Liege

相似试验